vs
American Healthcare REIT, Inc.（AHR）与特诺控股（TROX）财务数据对比。点击上方公司名可切换其他公司
特诺控股的季度营收约是American Healthcare REIT, Inc.的1.3倍（$730.0M vs $564.0M），American Healthcare REIT, Inc.净利率更高（1.9% vs -24.1%，领先26.0%），American Healthcare REIT, Inc.同比增速更快（13.5% vs 8.0%），过去两年American Healthcare REIT, Inc.的营收复合增速更高（11.7% vs -2.9%）
本公司是一家国际医疗房地产投资信托基金（REIT），总部位于美国阿拉巴马州伯明翰，主要在美国及欧洲地区收购、投资医疗机构与营利性医疗控股企业，物业收购多采用售后回租模式，租户通常签署长期三净租约。
特诺控股是一家业务遍及全球的美国化工企业，专注于钛制品领域，现有员工约6500名。在收购南非埃萨罗资源原有的矿砂业务后，特诺已成为全球规模最大的全产业链二氧化钛颜料供应商。二氧化钛颜料主要为涂料、塑料、纸张等产品增白增亮，特诺还拥有钛矿砂开采及加工业务。
AHR vs TROX — 直观对比
营收规模更大
TROX
是对方的1.3倍
$564.0M
营收增速更快
AHR
高出5.5%
8.0%
净利率更高
AHR
高出26.0%
-24.1%
两年增速更快
AHR
近两年复合增速
-2.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $564.0M | $730.0M |
| 净利润 | $10.8M | $-176.0M |
| 毛利率 | 14.8% | 5.3% |
| 营业利润率 | 19.8% | -15.6% |
| 净利率 | 1.9% | -24.1% |
| 营收同比 | 13.5% | 8.0% |
| 净利润同比 | 133.9% | -486.7% |
| 每股收益（稀释后） | $0.07 | $-1.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AHRTROX
| Q4 25 | $564.0M | $730.0M | ||
| Q3 25 | $532.1M | $699.0M | ||
| Q2 25 | $501.3M | $731.0M | ||
| Q1 25 | $497.2M | $738.0M | ||
| Q4 24 | $496.8M | $676.0M | ||
| Q3 24 | $476.8M | $804.0M | ||
| Q2 24 | $458.0M | $820.0M | ||
| Q1 24 | $452.1M | $774.0M |
净利润AHRTROX
| Q4 25 | $10.8M | $-176.0M | ||
| Q3 25 | $55.9M | $-99.0M | ||
| Q2 25 | $9.9M | $-84.0M | ||
| Q1 25 | $-6.8M | $-111.0M | ||
| Q4 24 | $-31.8M | $-30.0M | ||
| Q3 24 | $-4.1M | $-25.0M | ||
| Q2 24 | $2.0M | $16.0M | ||
| Q1 24 | $-3.9M | $-9.0M |
毛利率AHRTROX
| Q4 25 | 14.8% | 5.3% | ||
| Q3 25 | 14.6% | 7.4% | ||
| Q2 25 | 15.0% | 10.8% | ||
| Q1 25 | 13.0% | 13.4% | ||
| Q4 24 | 13.3% | 17.3% | ||
| Q3 24 | 12.5% | 15.9% | ||
| Q2 24 | 12.1% | 18.3% | ||
| Q1 24 | 10.7% | 15.5% |
营业利润率AHRTROX
| Q4 25 | 19.8% | -15.6% | ||
| Q3 25 | 19.9% | -6.2% | ||
| Q2 25 | 20.6% | -4.8% | ||
| Q1 25 | 19.0% | -8.3% | ||
| Q4 24 | 20.0% | 7.1% | ||
| Q3 24 | 19.6% | 6.7% | ||
| Q2 24 | 19.4% | 9.3% | ||
| Q1 24 | 18.2% | 5.3% |
净利率AHRTROX
| Q4 25 | 1.9% | -24.1% | ||
| Q3 25 | 10.5% | -14.2% | ||
| Q2 25 | 2.0% | -11.5% | ||
| Q1 25 | -1.4% | -15.0% | ||
| Q4 24 | -6.4% | -4.4% | ||
| Q3 24 | -0.9% | -3.1% | ||
| Q2 24 | 0.4% | 2.0% | ||
| Q1 24 | -0.9% | -1.2% |
每股收益（稀释后）AHRTROX
| Q4 25 | $0.07 | $-1.11 | ||
| Q3 25 | $0.33 | $-0.63 | ||
| Q2 25 | $0.06 | $-0.53 | ||
| Q1 25 | $-0.04 | $-0.70 | ||
| Q4 24 | $-0.23 | $-0.19 | ||
| Q3 24 | $-0.03 | $-0.16 | ||
| Q2 24 | $0.01 | $0.10 | ||
| Q1 24 | $-0.04 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $114.8M | $199.0M |
| 总债务越低越好 | — | $3.1B |
| 股东权益账面价值 | $3.3B | $1.4B |
| 总资产 | $5.4B | $6.2B |
| 负债/权益比越低杠杆越低 | — | 2.21× |
8季度趋势，按日历期对齐
现金及短期投资AHRTROX
| Q4 25 | $114.8M | $199.0M | ||
| Q3 25 | $147.4M | $185.0M | ||
| Q2 25 | $133.5M | $132.0M | ||
| Q1 25 | $86.1M | $138.0M | ||
| Q4 24 | $76.7M | $151.0M | ||
| Q3 24 | $67.8M | $167.0M | ||
| Q2 24 | $52.1M | $201.0M | ||
| Q1 24 | $77.0M | $152.0M |
总债务AHRTROX
| Q4 25 | — | $3.1B | ||
| Q3 25 | — | $3.1B | ||
| Q2 25 | — | $2.7B | ||
| Q1 25 | — | $2.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | — | $2.8B |
股东权益AHRTROX
| Q4 25 | $3.3B | $1.4B | ||
| Q3 25 | $2.7B | $1.6B | ||
| Q2 25 | $2.4B | $1.6B | ||
| Q1 25 | $2.3B | $1.7B | ||
| Q4 24 | $2.3B | $1.8B | ||
| Q3 24 | $2.2B | $1.9B | ||
| Q2 24 | $1.9B | $1.9B | ||
| Q1 24 | $2.0B | $1.9B |
总资产AHRTROX
| Q4 25 | $5.4B | $6.2B | ||
| Q3 25 | $4.8B | $6.3B | ||
| Q2 25 | $4.5B | $6.2B | ||
| Q1 25 | $4.5B | $6.1B | ||
| Q4 24 | $4.5B | $6.0B | ||
| Q3 24 | $4.7B | $6.2B | ||
| Q2 24 | $4.6B | $6.1B | ||
| Q1 24 | $4.7B | $6.0B |
负债/权益比AHRTROX
| Q4 25 | — | 2.21× | ||
| Q3 25 | — | 2.01× | ||
| Q2 25 | — | 1.67× | ||
| Q1 25 | — | 1.64× | ||
| Q4 24 | — | 1.57× | ||
| Q3 24 | — | 1.45× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 1.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $55.2M | $121.0M |
| 自由现金流经营现金流 - 资本支出 | — | $53.0M |
| 自由现金流率自由现金流/营收 | — | 7.3% |
| 资本支出强度资本支出/营收 | — | 9.3% |
| 现金转化率经营现金流/净利润 | 5.12× | — |
| 过去12个月自由现金流最近4个季度 | — | $-281.0M |
8季度趋势，按日历期对齐
经营现金流AHRTROX
| Q4 25 | $55.2M | $121.0M | ||
| Q3 25 | $107.2M | $-57.0M | ||
| Q2 25 | $71.5M | $28.0M | ||
| Q1 25 | $60.6M | $-32.0M | ||
| Q4 24 | $59.5M | $82.0M | ||
| Q3 24 | $63.1M | $87.0M | ||
| Q2 24 | $59.4M | $160.0M | ||
| Q1 24 | $-6.0M | $-29.0M |
自由现金流AHRTROX
| Q4 25 | — | $53.0M | ||
| Q3 25 | — | $-137.0M | ||
| Q2 25 | — | $-55.0M | ||
| Q1 25 | — | $-142.0M | ||
| Q4 24 | — | $-35.0M | ||
| Q3 24 | — | $-14.0M | ||
| Q2 24 | — | $84.0M | ||
| Q1 24 | — | $-105.0M |
自由现金流率AHRTROX
| Q4 25 | — | 7.3% | ||
| Q3 25 | — | -19.6% | ||
| Q2 25 | — | -7.5% | ||
| Q1 25 | — | -19.2% | ||
| Q4 24 | — | -5.2% | ||
| Q3 24 | — | -1.7% | ||
| Q2 24 | — | 10.2% | ||
| Q1 24 | — | -13.6% |
资本支出强度AHRTROX
| Q4 25 | — | 9.3% | ||
| Q3 25 | — | 11.4% | ||
| Q2 25 | — | 11.4% | ||
| Q1 25 | — | 14.9% | ||
| Q4 24 | — | 17.3% | ||
| Q3 24 | — | 12.6% | ||
| Q2 24 | — | 9.3% | ||
| Q1 24 | — | 9.8% |
现金转化率AHRTROX
| Q4 25 | 5.12× | — | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 7.21× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 30.02× | 10.00× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
TROX
| Ti O2 | $577.0M | 79% |
| Zircon | $78.0M | 11% |
| Idle Facility And Lower Of Cost Or Net Realizable Value Charges | $42.0M | 6% |
| Other | $20.0M | 3% |
| MGT | $13.0M | 2% |
